Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is announcing the renewal of certain FDA advisory committees by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the charters of the committees listed in the following table for an additional 2 years beyond charter expiration date. The new charters will be in effect until the dates of expiration listed in the following table. This notice is issued under the Federal Advisory Committee Act of October 6, 1972 (Public Law 92-463 (5 U.S.C. app. 2)).
Authority for these committees will expire on the dates indicated in the following table unless the Commissioner formally determines that renewal is in the public interest.Start Printed Page 26614
|Name of committee||Date of expiration|
|National Mammography Quality Assurance Advisory Committee||July 6, 2005|
|Nonprescription Drugs Advisory Committee||August 27, 2005|
|Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and Contaminants||December 2, 2005|
|Food Advisory Committee||December 18, 2005|
|Vaccines and Related Biological Products Advisory Committee||December 31, 2005|
|Advisory Committee for Pharmaceutical Science||January 22, 2006|
|Gastrointestinal Drugs Advisory Committee||March 3, 2006|
|Advisory Committee for Reproductive Health Drugs||March 23, 2006|
|Arthritis Advisory Committee||April 5, 2006|
|Veterinary Medicine Advisory Committee||April 24, 2006|
FOR FURTHER INFORMATION CONTACT:
Linda A. Sherman, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.End Further Info Start Signature
Dated: May 5, 2004.
Peter J. Pitts,
Associate Commissioner for External Relations.
[FR Doc. 04-10832 Filed 5-12-04; 8:45 am]
BILLING CODE 4160-01-S